Gaps in Diabetes Screening During Pregnancy and Postpartum

被引:72
|
作者
Blatt, Amy J. [1 ]
Nakamoto, Jon M. [1 ]
Kaufman, Harvey W. [1 ]
机构
[1] Quest Diagnost, San Juan Capistrano, CA USA
来源
OBSTETRICS AND GYNECOLOGY | 2011年 / 117卷 / 01期
关键词
MELLITUS; HYPERGLYCEMIA; PREVALENCE; CRITERIA; WOMEN;
D O I
10.1097/AOG.0b013e3181fe424b
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To estimate the screening rate and prevalence of gestational diabetes mellitus (GDM) and the screening rate and prevalence of postpartum diabetes, in a large, national sample of pregnant women. We also estimated the potential effects of the new International Association of Diabetes and Pregnancy Study Groups recommendations, which replace the 100-g oral glucose tolerance test (OGTT) with the 75-g OGTT, on GDM prevalence and gestational plasma glucose testing practices. METHODS: We identified pregnant women who used the laboratory services of Quest Diagnostics and who were screened for GDM and were tested postpartum. Gestational diabetes mellitus prevalence was calculated according to the current American Diabetes Association/Carpenter-Coustan criteria, and the new International Association of Diabetes and Pregnancy Study Groups criteria. RESULTS: Sixty-eight percent (632,820/924,873) of pregnant women aged 25 to 40 (ie, those not in a low-risk age group) who utilized the services of Quest Diagnostics during this study were screened for GDM. Of the entire adult pregnant population (ages 18-40) who received GDM screening, 5% (40,955/842,993) had positive test results under the current criteria. Nineteen percent (4,486/23,299) of those with GDM received postpartum diabetes testing within a 6-month period. Ninety percent (148,749/166,085) of all confirmatory GDM tests performed on pregnant women at Quest Diagnostics were the 100-g OGTT. The number of women with GDM after receiving the 75-g OGTT would have doubled under the International Association of Diabetes and Pregnancy Study Groups criteria. CONCLUSION: Many women may not be receiving GDM screening during pregnancy. Postpartum diabetes screening rates after pregnancy remain low. Adoption of the new International Association of Diabetes and Pregnancy Study Groups criteria would require a significant change in current clinical practice. (Obstet Gynecol 2011; 117:61-8) DOI: 10.1097/AOG.0b013e3181fe424b
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [21] Postpartum management of diabetes pregnancy
    Hossain, Nazli
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2016, 66 (11)
  • [22] Diabetes in Pregnancy: Preconception to Postpartum
    Healy, Amber M.
    PRIMARY CARE, 2022, 49 (02): : 287 - 300
  • [23] Observational evidence in support of screening for depression during pregnancy and the postpartum period
    Premji, Shainur
    McNeil, Deborah A.
    Spackman, Eldon
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (43) : E1487 - E1487
  • [24] Glucose levels during gestational diabetes pregnancy and the risk of developing postpartum diabetes or prediabetes
    Chadakarn Phaloprakarn
    Siriwan Tangjitgamol
    BMC Pregnancy and Childbirth, 22
  • [25] Glucose levels during gestational diabetes pregnancy and the risk of developing postpartum diabetes or prediabetes
    Phaloprakarn, Chadakarn
    Tangjitgamol, Siriwan
    BMC PREGNANCY AND CHILDBIRTH, 2022, 22 (01)
  • [26] Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls
    Boyadzhieva, M.
    Atanasova, I.
    Zacharieva, S.
    Kedikova, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (11): : 944 - 949
  • [27] Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls
    M. Boyadzhieva
    I. Atanasova
    S. Zacharieva
    S. Kedikova
    Journal of Endocrinological Investigation, 2013, 36 : 944 - 949
  • [28] Gestational diabetes is associated with an aberrant gut microbiota during pregnancy and postpartum
    Crusell, M. K. W.
    Hansen, T.
    Nielsen, T.
    Allin, K.
    Ruehlemann, M.
    Damm, Peter
    Vestergaard, Henrik
    Roerbye, C.
    Joergensen, N.
    Christiansen, O. B.
    Heinsen, F. -A.
    Franke, A.
    Hansen, T.
    Lauenborg, J.
    Pedersen, O.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2018, 128 : 56 - 56
  • [29] DDAVP TREATMENT OF DIABETES-INSIPIDUS DURING PREGNANCY AND THE POSTPARTUM PERIOD
    BURROW, GN
    WASSENAAR, W
    ROBERTSON, GL
    SEHL, H
    ACTA ENDOCRINOLOGICA, 1981, 97 (01): : 23 - 25
  • [30] Prevalence of diabetic retinopathy in women with pregestational diabetes during pregnancy and the postpartum
    Widyaputri, Felicia
    Rogers, Sophie L.
    Khong, Edmund W. C.
    Nankervis, Alison J.
    Conn, Jennifer J.
    Sasongko, Muhammad B.
    Shub, Alexis
    Fagan, Xavier J.
    Guest, Daryl
    Symons, Robert C. A.
    Lim, Lyndell L.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (07): : 757 - 767